|
(HealthScout). Two law firms are expanding
their legal fight against the Swiss maker of defective prosthetic
hips that may have been implanted in thousands of Americans since
1997.
More than a
dozen patients and their attorneys filed a federal class-action
suit in San Francisco against Sulzer Medica on Feb. 13, and today
lawyers went to court in New York state to demand that the company
pay to monitor people with the questionable implants.
Representatives
of Sulzer Orthopedics acknowledge that their Inter-Op Acetabular
hip shellswhich make up part of a hip implantare
defective. Sulzer Orthopedics is part of Sulzer Medica. About 17,500
people have received the implants, with 90 percent of those in the
United States.
According to
Sulzer, which also has a base in Austin, Texas, an "unacceptable
level" of lubricant was left on the surface of the shells when they
were made. The lubricant can prevent the implants from bonding properly
with the hip bone, meaning that the hip can detach from the leg.
The company
said it's difficult to know how many of the hip implants will fail,
although it has documented 129 cases of "loosening," all of which
occurred in the first six months after an implant surgery.
The company
is voluntarily recalling the implants and paying for the out-of-pocket
costs of surgeries to remove the implants. Sulzer Orthopedics is
also willing to discuss financial settlements for lost wages and
pain and suffering, said company spokesman Jim Moore.
"We are profoundly
disturbed by our own failure," he said. "It's as unacceptable to
us as it is to the surgeons and the patients. We're endeavoring
to do everything we can to make it right."
But patients
and lawyers say the company isn't doing enough. Sulzer is not paying
to monitor patients who received the implant, said San Francisco-based
lead attorney Richard Heimann in a statement. His firm is taking
part in the lawsuits in both California and New York.
"To date, Sulzer's
response to this crisis has been grossly inadequate," Heimann said
in the statement made before a press conference today in the Warwick
Hotel in New York City.
In the New York
suit, lawyers are demanding that Sulzer set up a fund for monitoring
patients, and hand over any profits from the sales of the flawed
devices.
An estimated
160,000 hip replacement surgeries are completed each year, and Sulzer
manufactures about 12 percent of the implants used.
Despite advances
over the last four decades, hip replacement surgery remains a serious
operation, said William Tipton, MD, executive vice president of
the American Academy of Orthopaedic Surgeons.
"I tell people
to make sure you've tried everything else not operativecrutches,
decreasing or modifying your activity, medication, anti-inflammatoriesbefore
you subject yourself to this," he said. "This is not a procedure
to mess around with."
Hip problems
tend to hit after the age of 50 or 55, when the surfaces of joints
begin to deteriorate, he said. Those surfaces are coated with cartilage,
which acts both as a buffer and a kind of lubricant. When the cartilage
disappears -- due to injury, disease or other cause -- only bone
is left, causing bone-against-bone friction and pain.
While aging
is clearly a factor, no one knows why some older people suffer from
hip pain and others don't, he said.
Implants replace
part of the bone in ball-and-socket joints, allowing them to move
more freely, Tipton said. But the implants wear out, often after
just 10 to 15 years, he said.
If patients
do find out that they have implants that are potentially defective,
they should not rush to have them replaced, Tipton said. "Every
time you do one of these [operations], you run the risks that are
always there the first time. I wouldn't have them pull out a hip
prosthesis if it's not giving them problems."
Moore, the Sulzer
company spokesman, agreed. He said removal of implants is not necessary
if there are no adverse symptoms. Implants that have been in place
for more than six months or a year should not have problems, he
said.
Copyright
© 2001 Rx Remedy, Inc.
This
is a News story from HealthScout,
a service of Rx Remedy, Inc.
|